2022
DOI: 10.1128/iai.00597-21
|View full text |Cite
|
Sign up to set email alerts
|

N , N -Dimethyldithiocarbamate Elicits Pneumococcal Hypersensitivity to Copper and Macrophage-Mediated Clearance

Abstract: Streptococcus pneumoniae is a Gram-positive, encapsulated bacterium that is a significant cause of disease burden in pediatric and elderly populations. The rise in unencapsulated disease-causing strains and antimicrobial resistance in S. pneumoniae has increased the need for developing new antimicrobial strategies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(16 citation statements)
references
References 80 publications
2
14
0
Order By: Relevance
“…We observed a significant decrease in bacterial titers in the blood and lungs 48 hours post-infection in 8-week-old BALB/c mice given 25 µL of 10 mM Compound 3 (approximately 1.6 mg/kg), but no significant decrease was noted for mice given the same dosage of Compound 4 (Figure 5A-D). Further, as previously observed with DMDC and copper (21), the combination treatment of Compound 3 plus copper also made the pneumococcus more susceptible to activated macrophage mediated killing via a macrophage killing assay as compared to no treatment, copper, or Compound 3 alone (Figure 6). These data show that Compound 3 is a promising antibiotic against S. pneumoniae TIGR4 with efficacy in vivo .…”
Section: Resultssupporting
confidence: 76%
See 4 more Smart Citations
“…We observed a significant decrease in bacterial titers in the blood and lungs 48 hours post-infection in 8-week-old BALB/c mice given 25 µL of 10 mM Compound 3 (approximately 1.6 mg/kg), but no significant decrease was noted for mice given the same dosage of Compound 4 (Figure 5A-D). Further, as previously observed with DMDC and copper (21), the combination treatment of Compound 3 plus copper also made the pneumococcus more susceptible to activated macrophage mediated killing via a macrophage killing assay as compared to no treatment, copper, or Compound 3 alone (Figure 6). These data show that Compound 3 is a promising antibiotic against S. pneumoniae TIGR4 with efficacy in vivo .…”
Section: Resultssupporting
confidence: 76%
“…Compound 3 and Compound 4 showed in vitro inhibition in growth curves against TIGR4 while Compound 1, Compound 2, and Compound 5 had no effect (Figure 1 and Table 1). Further, Compounds 3 and 4 had seemingly increased killing capacity after 30 minutes compared to DMDC, which didn't start showing killing until the 60 minute time point, thus indicating potential advancement in modifying dithiocarbamates as a copper dependent antimicrobial (21). After identifying that these DMDC derivatives could force copper into the bacteria and chelate copper, we observed a reduced bacterial burden during a murine respiratory infection using Compound 3 (Figure 2, 3, 4, 5, 7, 8).…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations